Financial Statements · From SEC 10-K & 10-Q XBRL Filings
CRH Revenue & Financial Statements
CRH reported revenue of $37.4B for the fiscal year ended December 31, 2025, up 5.3% year over year, with net income of $3.8B and diluted EPS of $5.51.
- Company
- CRH CRH
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 3 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | 34.9B | 35.6B | 37.4B |
| Cost of revenue | 23.0B | 22.9B | 23.9B |
| Gross profit | 12.0B | 12.7B | 13.5B |
| Operating income | 4.2B | 4.9B | 5.4B |
| Pretax income | 1.3B | 1.6B | 2.0B |
| Net income | 3.3B | 3.1B | 3.8B |
| Diluted EPS | 4.33 | 5.02 | 5.51 |
| EBITDA | 5.8B | 6.7B | 7.6B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.5B | 9.7B | 10.5B | 8.9B | 6.8B | 10.2B | 11.1B | 9.4B |
| Cost of revenue | 4.7B | 6.0B | 6.5B | 5.7B | 4.9B | 6.2B | 6.8B | 6.1B |
| Gross profit | 1.8B | 3.7B | 4.1B | 3.2B | 1.8B | 4.0B | 4.3B | 3.4B |
| Operating income | 28.0M | 1.8B | 2.0B | 1.1B | 18.0M | 1.9B | 2.1B | 1.4B |
| Pretax income | 99.0M | 1.7B | 1.9B | 987.0M | (146.0M) | 1.8B | 1.9B | 1.3B |
| Net income | (65.0M) | 1.3B | 1.7B | 197.0M | 105.0M | 1.8B | 1.5B | 1.0B |
| Diluted EPS | 0.16 | 1.88 | 1.97 | 1.02 | -0.15 | 1.94 | 2.21 | 1.52 |
| EBITDA | 425.0M | — | 2.4B | 1.6B | 495.0M | — | — | — |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total assets | 47.5B | 50.6B | 58.3B |
| Current assets | 16.9B | 14.1B | 15.3B |
| Cash & equivalents | 6.3B | 3.7B | 4.1B |
| Total liabilities | 25.8B | 27.8B | 32.9B |
| Current liabilities | 10.0B | 10.3B | 8.8B |
| Long-term debt | 9.8B | 11.0B | 16.5B |
| Total debt | 9.9B | 11.1B | 16.6B |
| Stockholders’ equity | 20.9B | 21.6B | 24.0B |
| Net debt | 3.5B | 7.4B | 12.5B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | 5.0B | 5.0B | 5.6B |
| Investing cash flow | (2.4B) | (6.3B) | (6.0B) |
| Financing cash flow | (2.4B) | (1.2B) | 596.0M |
| Capital expenditure | 1.8B | 2.6B | 2.7B |
| Free cash flow | 3.2B | 2.4B | 2.9B |
| Dividends paid | — | — | — |
| Stock-based compensation | 123.0M | 125.0M | 143.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every CRH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.